CLEVELAND, Ohio, Nov. 13 (TNSres) -- The Cleveland Clinic issued the following news release on Nov. 11, 2023: * * * SELECT trial presented by Cleveland Clinic physician at the American Heart Association's Scientific Sessions 2023 * * * Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who don't have diabetes.   more